Krsnaa Diagnostics Ltd

NSE : KRSNAA24 Jan 2025

Healthcare

₹

-13.75 (-1.64%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd

Healthcare

NSE : KRSNAA24 Jan 2025

₹

-13.75 (-1.64%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
18-May-2024	D	Recommendation of final dividend at INR 2.50/- per equity share, a payout of 50% of face value INR 5.00 each, for FY 2023-24.	13-Sep-2024
27-May-2023	D	Board has recommended a Dividend of Rs. 2.75/- per Equity Share, subject to approval of Shareholders at the Annual General Meeting of the company.	15-Sep-2023
28-May-2022	D	Board of Directors at its meeting held on 28-May-2022, Declared Dividend of Rs. 2.50 per equity share	15-Sep-2022
03-Jan-2025	BC	Krsna Diagnostics (Mumbai) Pvt Ltd	27-Dec-2024
18-Oct-2024	BC	Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Pursuant to the provisions of Regulation	25-Oct-2024
07-Aug-2024	BC	AGM 21/09/2024 Proceedings of 14th Annual General Meeting of the Company. (As Per BSE Announcement Dated on: 21/09/2024)	21-Sep-2024
07-Aug-2024	BC	Annual General Meeting	14-Sep-2024
07-Aug-2024	BC	Rs.2.5000 per share(50%)Final Dividend	13-Sep-2024

No Rights has been declared by KRSNAA

Book Closure

Record Date	Split Date	Purpose
27-Dec-2024	-	Krsna Diagnostics (Mumbai) Pvt Ltd
25-Oct-2024	-	Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Pursuant to the provisions of Regulation
21-Sep-2024	-	AGM 21/09/2024 Proceedings of 14th Annual General Meeting of the Company. (As Per BSE Announcement Dated on: 21/09/2024)
14-Sep-2024	01 Jan'1900	Annual General Meeting
13-Sep-2024	-	Rs.2.5000 per share(50%)Final Dividend

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Krsnaa Diagnostics Ltd ₹823.05(-13.75/-1.64%)	823.05	-13.75	2,702.01	24.90	37.35	3.17
Poly Medicure Ltd ₹2,431.95(+36.00/1.50%)	2,431.95	+36.00	24,277.13	68.56	83.26	9.43
Fortis Healthcare Ltd ₹616.50(-19.40/-3.05%)	616.50	-19.40	48,007.79	51.39	253.29	5.29
Syngene International Ltd ₹797.35(-49.65/-5.86%)	797.35	-49.65	34,094.88	24.36	77.66	7.90
Indegene Ltd ₹657.00(-5.40/-0.82%)	657.00	-5.40	15,849.17	16.03	101.69	8.95
GPT Healthcare Ltd ₹172.89(-0.51/-0.29%)	172.89	-0.51	1,422.83	-9.59	28.96	6.15

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	22.13	88.32	24.68	-46.65	-14.52
Net Cash from Operating Activities	24.39	75.48	128.71	118.66	37.81
Net Cash Used In Investing Activities	-128.88	-108.54	-241.10	-67.37	-76.65
Net Cash Used In Financing Activities	84.21	-33.13	176.04	20.03	5.78
Net Inc./Dec In Cash And Cash Equivalents	-20.27	-66.19	63.65	71.32	-33.06
Cash And Cash Equivalents At End Of The Year	1.86	22.13	88.32	24.68	-47.58

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

27.24%

FII Shareholding

4.04%

DII Shareholding

14.46%

Public Shareholding

54.27%

**Promoter pledged shareholding 27.24%

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd is in the Healthcare sector, having a market capitalization of Rs. 2694.58 crores. It has reported a sales of Rs. 178.72 crores and a net profit of Rs. 21.97 crores for the quarter ended December 2018. The company management includes Rajendra Mutha, Chetan Desai,Rajendra Mutha,Pallavi Bhatevara,,Yash Mutha,Prem Pradeep,Chhaya Palrecha,Rajiva Ranjan Verma,Adesh Gupta,Sujoy Sudipta Bose (Krsnaa Diagnostics Ltd) among others.

Chairman

Rajendra Mutha

Registered office

S.No. 243/A Hissa No.6 Near,Chinchwad Station Chinchwad,Pune,Maharashtra,411019

FAX :

Background

Incorporation Year2010

Face Value₹5

Market Lot1